Tumor promoting or tumor suppressing of NF-κB, a matter of cell context dependency

International Reviews of Immunology

Volumn 27, Issue 4, 2008, Pages 183-204

  Chen, Fei ^a,b   Beezhold, Kevin ^a,b   Castranova, Vince ^a,c  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

^c WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Epigenetics; Histone methylation; JNK; NF B; ROS; Tumor suppressing

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE;

APOPTOSIS; CANCER INHIBITION; CARCINOGENESIS; CELL DIFFERENTIATION; CELL GROWTH; CELL MATURATION; CELL TYPE; EPIGENETICS; HUMAN; NEOPLASM; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; REVIEW; TUMOR PROMOTION; UPREGULATION; VIRUS GENE;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; DNA METHYLATION; EPIGENESIS, GENETIC; FREE RADICAL SCAVENGERS; HEMATOLOGIC NEOPLASMS; HUMANS; LIVER NEOPLASMS; NEOPLASMS, EXPERIMENTAL; NF-KAPPA B; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

EID: 46049090192     PISSN: 08830185     EISSN: 15635244     Source Type: Journal    
DOI: 10.1080/08830180802130327     Document Type: Review

References (67)

1. R. Sen and D. Baltimore, Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46: 705-716, 1986.
2. M.L. Atchison and R.P. Perry, The role of the kappa enhancer and its binding factor nf-kappa b in the developmental regulation of kappa gene transcription. Cell 48: 121-128, 1987.
3. R. Sen and D. Baltimore, Inducibility of kappa immunoglobulin enhancer-binding protein nf-kappa b by a posttranslational mechanism. Cell 47: 921-928, 1986.
4. L. Lin and S. Ghosh, A glycine-rich region in nf-kappab p105 functions as a processing signal for the generation of the p50 subunit. Mol Cell Biol 16: 2248-2254, 1996.
5. L. Lin, G.N. DeMartino, and W.C. Greene, Cotranslational biogenesis of nf-kappab p50 by the 26s proteasome. Cell 92: 819-828, 1998.
6. F. Chen, D. Bhatia, Q. Chang, and V. Castranova, Finding nemo by k63-linked polyubiquitin chain. Cell Death Differ 13: 1835-1838, 2006.
7. F. Chen, V. Castranova, and X. Shi, New insights into the role of nuclear factor-kappab in cell growth regulation. Am J Pathol 159: 387-397, 2001.
8. F. Chen, V. Castranova, X. Shi, and L.M. Demers, New insights into the role of nuclear factor-kappab, a ubiquitous transcription factor in the initiation of diseases. Clin Chem 45: 7-17, 1999.
9. W.W. Lin and M. Karin, A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 117: 1175-1183, 2007.
10. S.P. Hussain, L.J. Hofseth, and C.C. Harris, Radical causes of cancer. Nat Rev Cancer 3: 276-285, 2003.
11. F. Chen, L.M. Demers, V. Vallyathan, Y. Lu, V. Castranova, and X. Shi, Involvement of 5′-flanking kappab-like sites within bcl-x gene in silica-induced bcl-x expression. J Biol Chem274: 35591-35595, 1999.
12. E.P. Dixon, D.T. Stephenson, J.A. Clemens, and S.P. Little, Bcl-xshort is elevated following severe global ischemia in rat brains. Brain Res 776: 222-229, 1997.
13. H.H. Lee, H. Dadgostar, Q. Cheng, J. Shu, and G. Cheng, Nf-kappab-mediated up-regulation of bcl-x and bfl-1/a1 is required for cd40 survival signaling in b lymphocytes. Proc Natl Acad Sci USA 96: 9136-9141, 1999.
14. J. Houldsworth, S. Mathew, P.H. Rao, K. Dyomina, D.C. Louie, N. Parsa, K. Offit, and R. S. Chaganti, Rel proto-oncogene is frequently amplified in extranodal diffuse large cell lymphoma. Blood 87: 25-29, 1996.
15. S. Liptay, T. Seriu, C.R. Bartram, and R.M. Schmid, Germline configuration of nfkb2, c-rel and bcl3 in childhood acute lymphoblastic leukemia (all). Leukemia 11: 1364-1366, 1997.
16. G. Courtois and T.D. Gilmore, Mutations in the nf-kappab signaling pathway: Implications for human disease. Oncogene 25: 6831-6843, 2006.
17. P. Ciana, A. Neri, C. Cappellini, F. Cavallo, M. Pomati, C.C. Chang, A.T. Maiolo, and L. Lombardi, Constitutive expression of lymphoma-associated nfkb-2/lyt-10 proteins is tumorigenic in murine fibroblasts. Oncogene 14: 1805-1810, 1997.
18. K.M. Wood, M. Roff, and R.T. Hay, Defective ikappabalpha in hodgkin cell lines with constitutively active nf-kappab. Oncogene 16: 2131-2139, 1998.
19. T.R. Brummelkamp, S.M. Nijman, A.M. Dirac, and R. Bernards, Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating nf-kappab. Nature 424: 797-801, 2003.
20. G.R. Bignell, W. Warren, S. Seal, M. Takahashi, E. Rapley, R. Barfoot, H. Green, C. Brown, P.J. Biggs, S.R. Lakhani, C. Jones, J. Hansen, E. Blair, B. Hofmann, R. Siebert, G. Turner, D.G. Evans, C. Schrander-Stumpel, F.A. Beemer, A. van Den Ouweland, D. Halley, B. Delpech, M.G. Cleveland, I. Leigh, J. Leisti, and S. Rasmussen, Identification of the familial cylindromatosis tumour-suppressor gene. Nat Genet 25: 160-165, 2000.
21. C.M. Annunziata, R.E. Davis, Y. Demchenko, W. Bellamy, A. Gabrea, F. Zhan, G. Lenz, I. Hanamura, G. Wright, W. Xiao, S. Dave, E.M. Hurt, B. Tan, H. Zhao, O. Stephens, M. Santra, D.R. Williams, L. Dang, B. Barlogie, J.D. Shaughnessy, Jr., W.M. Kuehl, L.M. Staudt, Frequent engagement of the classical and alternative nf-kappab pathways by diverse genetic abnormalities in multiple myeloma. Cancer Cell 12: 115-130, 2007.
22. J.J. Keats, R. Fonseca, M. Chesi, R. Schop, A. Baker, W.J. Chng, S. Van Wier, R. Tiedemann, C. X. Shi, M. Sebag, E. Braggio, T. Henry, Y.X. Zhu, H. Fogle, T. Price-Troska, G. Ahmann, C. Mancini, L.A. Brents, S. Kumar, P. Greipp, A. Dispenzieri, B. Bryant, G. Mulligan, L. Bruhn, M. Barrett, R. Valdez, J. Trent, A.K. Stewart, J. Carpten, and P.L. Bergsagel, Promiscuous mutations activate the noncanonical nf-kappab pathway in multiple myeloma. Cancer Cell 12: 131-144, 2007.
23. J.D. Woronicz, X. Gao, Z. Cao, M. Rothe, and D.V. Goeddel, Ikappab kinase-beta: Nf-kappab activation and complex formation with ikappab kinase-alpha and nik. Science 278: 866-869, 1997.
24. M. Karin, Nuclear factor-kappab in cancer development and progression. Nature 441: 431-436, 2006.
25. F. Chen, Endogenous inhibitors of nuclear factor-kappab, an opportunity for cancer control. Cancer Res 64: 8135-8138, 2004.
26. N.D. Perkins, The rel/nf-kappa b family: Friend and foe. Trends Biochem Sci 25: 434-440, 2000.
27. A.S. Baldwin, Control of oncogenesis and cancer therapy resistance by the transcription factor nf-kappab. J Clin Invest 107: 241-246, 2001.
28. T.D. Gilmore, Multiple myeloma: Lusting for nf-kappab. Cancer Cell 12: 95-97, 2007.
29. F. Chen and V. Castranova, Nuclear factor-kappab, an unappreciated tumor suppressor. Cancer Res 67: 11093-11098, 2007.
30. N.D. Perkins, Nf-kappab: Tumor promoter or suppressor? Trends Cell Biol 14: 64-69, 2004.
31. S. Kasibhatla, T. Brunner, L. Genestier, F. Echeverri, A. Mahboubi, and D.R. Green, DNA damaging agents induce expression of fas ligand and subsequent apoptosis in t lymphocytes via the activation of nf-kappa b and ap-1. Mol Cell 1: 543-551, 1998.
32. T. Hettmann, J. DiDonato, M. Karin, and J.M. Leiden, An essential role for nuclear factor kappab in promoting double positive thymocyte apoptosis. J Exp Med 189: 145-158, 1999.
33. J. Bash, W.X. Zong, and C. Gelinas, C-rel arrests the proliferation of hela cells and affects critical regulators of the g1/s-phase transition. Mol Cell Biol 17: 6526-6536, 1997.
34. C.S. Seitz, Q. Lin, H. Deng, and P.A. Khavari, Alterations in nf-kappab function in transgenic epithelial tissue demonstrate a growth inhibitory role for nf-kappab. Proc Natl Acad Sci U S A 95: 2307-2312, 1998.
35. B. Liu, E. Park, F. Zhu, T. Bustos, J. Liu, J. Shen, S.M. Fischer, and Y. Hu, A critical role for i kappab kinase alpha in the development of human and mouse squamous cell carcinomas. Proc Natl Acad Sci USA 103: 17202-17207 2006.
36. S. Maeda, H. Kamata, J.L. Luo, H. Leffert, and M. Karin, Ikkbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 121: 977-990, 2005.
37. T. Luedde, N. Beraza, V. Kotsikoris, G. van Loo, A. Nenci, R. De Vos , T. Roskams, C. Trautwein, and M. Pasparakis, Deletion of nemo/ikkgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma. Cancer Cell 11: 119-132, 2007.
38. Y. Zhang and F. Chen, Reactive oxygen species (ros), troublemakers between nuclear factor-kappab (nf-kappab) and c-jun nh(2)-terminal kinase (jnk). Cancer Res 64: 1902-1905, 2004.
39. F. Chen, Y. Lu, Z. Zhang, V. Vallyathan, M. Ding, V. Castranova, and X. Shi, Opposite effect of nf-kappa b and c-jun n-terminal kinase on p53-independent gadd45 induction by arsenite. J Biol Chem276: 11414-11419, 2001.
40. E. De Smaele, F. Zazzeroni, S. Papa, D.U. Nguyen, R. Jin, J. Jones, R. Cong, and G. Franzoso, Induction of gadd45beta by nf-kappab downregulates pro-apoptotic jnk signalling. Nature 414: 308-313, 2001.
41. G. Tang, Y. Minemoto, B. Dibling, N.H. Purcell, Z. Li, M. Karin, and A. Lin, Inhibition of jnk activation through nf-kappab target genes. Nature 414: 313-317, 2001.
42. L.E. Heasley and S.Y. Han, Jnk regulation of oncogenesis. Mol Cells 21: 167-173, 2006.
43. N. Chen, M. Nomura, Q.B. She, W.Y. Ma, A.M. Bode, L. Wang, R.A. Flavell, and Z. Dong, Suppression of skin tumorigenesis in c-jun nh(2)-terminal kinase-2-deficient mice. Cancer Res 61: 3908-3912, 2001.
44. F. Bost, R. McKay, M. Bost, O. Potapova, N.M. Dean, and D. Mercola, The jun kinase 2 isoform is preferentially required for epidermal growth factor-induced transformation of human a549 lung carcinoma cells. Mol Cell Biol 19: 1938-1949, 1999.
45. R. Schreck, K. Albermann, and P.A. Baeuerle, Nuclear factor kappa b: An oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Radic Res Commun 17: 221-237, 1992.
46. K.C. Das, Y. Lewis-Molock, and C.W. White, Activation of nf-kappa b and elevation of mnsod gene expression by thiol reducing agents in lung adenocarcinoma (a549) cells. Am J Physiol 269: L588-602, 1995.
47. S. Sakon, X. Xue, M. Takekawa, T. Sasazuki, T. Okazaki, Y. Kojima, J.H. Piao, H. Yagita, K. Okumura, T. Doi, and H. Nakano, Nf-kappab inhibits tnf-induced accumulation of ros thatmediate prolongedmapk activation and necrotic cell death. EMBO J 22: 3898-3909, 2003.
48. F. Chen, V. Castranova, Z. Li, M. Karin, X. Shi, Inhibitor of nuclear factor kappab kinase deficiency enhances oxidative stress and prolongs c-jun nh2-terminal kinase activation induced by arsenic. Cancer Res 63: 7689-7693, 2003.
49. F.P. Guengerich, Common and uncommon cytochrome p450 reactions related to metabolism and chemical toxicity. Chem Res Toxicol 14: 611-650, 2001.
50. Z. Peng, L. Peng, Y. Fan, E. Zandi, H.G. Shertzer, and Y. Xia, A critical role for ikappab kinase beta in metallothionein-1 expression and protection against arsenic toxicity. J Biol Chem 282: 21487-21496, 2007.
51. J.M. Slack, Conrad Hal Waddington: The last renaissance biologist? Nat Rev Genet 3: 889-895, 2002.
52. C.H. Waddington, Intruduction to Modern Genetics. London: George Allen & Unwin, 1939.
53. R. Holliday Epigenetics: A historical overview. Epigenetics 1: 76-80, 2006
54. J.R. Whetstine, A. Nottke, F. Lan, M. Huarte, S. Smolikov, Z. Chen, E. Spooner, E. Li, G. Zhang, M. Colaiacovo, and Y. Shi: Reversal of histone lysine trimethylation by the jmjd2 family of histone demethylases. Cell 125: 467-481, 2006.
55. A.J. Bannister and T. Kouzarides, Reversing histone methylation. Nature 436: 1103-1106, 2005.
56. Y. Shi, F. Lan, C. Matson, P. Mulligan, J.R. Whetstine, P.A. Cole, R.A. Casero, and Y. Shi, Histone demethylation mediated by the nuclear amine oxidase homolog lsd1. Cell 119: 941-953, 2004.
57. P.A. Cloos, J. Christensen, K. Agger, A. Maiolica, J. Rappsilber, T. Antal, K.H. Hansen, and K. Helin, The putative oncogene gasc1 demethylates tri- and dimethylated lysine 9 on histone h3. Nature 442: 307-311, 2006.
58. B.D. Fodor, S. Kubicek, M. Yonezawa, R.J. O'Sullivan, R. Sengupta, L. Perez-Burgos, S. Opravil, K. Mechtler, G. Schotta, and T. Jenuwein, Jmjd2b antagonizes h3k9 trimethylation at pericentric heterochromatin in mammalian cells. Genes Dev 20: 1557-1562, 2006.
59. Y. Tsukada, J. Fang, H. Erdjument-Bromage, M.E. Warren, C.H. Borchers, P. Tempst, and Y. Zhang, Histone demethylation by a family of jmjc domain-containing proteins. Nature 439: 811-816, 2006.
60. K. Yamane, C. Toumazou, Y. Tsukada, H. Erdjument-Bromage, P. Tempst, J. Wong, and Y. Zhang, Jhdm2a, a jmjc-containing h3k9 demethylase, facilitates transcription activation by androgen receptor. Cell 125: 483-495, 2006.
61. Y. Huyen, O. Zgheib, R.A. Ditullio, Jr., V.G. Gorgoulis, P. Zacharatos, T.J. Petty, E.A. Sheston, H.S. Mellert, E.S. Stavridi, and T.D. Halazonetis, Methylated lysine 79 of histone h3 targets 53bp1 to DNA double-strand breaks. Nature 432: 406-411, 2004.
62. F. De Santa, M.G. Totaro, E. Prosperini, S. Notarbartolo, G. Testa, and G. Natoli, The histone h3 lysine-27 demethylase jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing. Cell 130: 1083-1094, 2007.
63. F. Chen, Y. Lu, V. Castranova, Z. Li, M. Karin, Loss of ikkbeta promotes migration and proliferation of mouse embryo fibroblast cells. J Biol Chem281: 37142-37149, 2006.
64. J.T. Irelan, T.J. Murphy, P.D. DeJesus, H. Teo, D. Xu, M.A. Gomez-Ferreria, Y. Zhou, L. J. Miraglia, D.R. Rines, I.M. Verma, D.J. Sharp, V. Tergaonkar, and S.K. Chanda, A role for ikappab kinase 2 in bipolar spindle assembly. Proc Natl Acad Sci U S A 104: 16940-16945, 2007.
65. S. Prajapati, Z. Tu, Y. Yamamoto, and R.B. Gaynor, Ikkalpha regulates the mitotic phase of the cell cycle by modulating aurora a phosphorylation. Cell Cycle 5: 2371-2380, 2006.
66. R.A. Ihrie, M.R. Marques, B.T. Nguyen, J.S. Horner, C. Papazoglu, R.T. Bronson, A.A. Mills, and L.D. Attardi, Perp is a p63-regulated gene essential for epithelial integrity. Cell 120: 843-856, 2005.
67. T.D. Gilmore, and M. Herscovitch, Inhibitors of nf-kappab signaling: 785 and counting. Oncogene 25: 6887-6899, 2006.